Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Kempharm Inc (KMPH)

3.85 +0.05 (+1.32%)

10/17/2017  3:59pm

Open:

3.85

Pre. Close:

3.80

High:

3.90

Low:

3.75

Volume:

12,902

Market Cap:

56.43M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.97 - 4.05

4.05 - 4.18

Low:

3.57 - 3.6

3.6 - 3.65

Close:

3.76 - 3.85

3.85 - 3.99

Technical analysis  (as of: 2017-10-17 4:39:06 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 4.91     One year: 5.73

Support:

Support1: 3.55    Support2: 3.15

Resistance:

Resistance1: 4.20    Resistance2: 4.91

Pivot:

3.83

Moving Averages:

MA(5): 3.81     MA(20): 3.82

MA(100): 3.52     MA(250): 3.75

MACD:

MACD(12,26): 0.11     Signal(12,26,9): 0.14

%K %D:

%K(14,3): 33.33     %D(3): 34.90

RSI:

RSI(14): 55.83

52-Week:

High: 5.40  Low: 2.45  Change(%): -1.3

Average Vol(K):

3-Month: 6182  10-Days 2259

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
KMPH has closed below upper band by 45.2%. Bollinger Bands are 55.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to KMPH's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 10 Aug 2017 20:03:45 GMT
KemPharm, Inc. Reports Second Quarter 2017 Results

Tue, 17 Oct 2017 11:03:45 GMT
Taking Aim at Shares of KemPharm, Inc. (NasdaqGM:KMPH)

Mon, 27 Mar 2017 11:26:15 GMT
KemPharm to Present at the 2nd Annual Neuroscience Biopartnering and ...

Wed, 26 Oct 2016 13:04:34 GMT
Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics ...

Mon, 16 Oct 2017 01:06:52 GMT
EPS for KemPharm Inc (KMPH) Expected At $-0.69

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

8.39

% Held by Insiders

37.41

% Held by Institutions

41.42

Shares Short (K)

492

Shares Short Prior Month (K)

505

Stock Financials

EPS

-3.100

EPS Est. Current Year

-2.720

EPS Est. Next Year

-2.300

EPS Est. Next Quarter

-0.700

Forward EPS

-2.298

Book Value (p.s.)

-2.680

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-24.4

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.289

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.63

Levered Free Cash Flow (M)

-16.76

FoxReading.com

Valuation

P/E

-1.24

P/E Growth Ratio

0.01

P/BV

-1.44

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.